Skip to content

Group Music Therapy for Acquired Brain Injury

Meraki: Music Therapy Protocol for People With Acquired Brain Injury

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06343662
Acronym
Meraki_ABI
Enrollment
27
Registered
2024-04-02
Start date
2024-03-01
Completion date
2025-09-30
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Brain Injury

Keywords

music therapy-based treatment, psychological intervention, discomfort, Acquired Brain Injury

Brief summary

The study aims to analyse the impact of music therapy-based treatment on the comfort and well-being of patients with acquired brain injury (ABI). To achieve this objective, it is proposed to validate and implement a music therapy-based assessment and treatment protocol. The protocol will be tested in a pilot sample to improve adaptation to the disease and promote integration with the usual health measures of patients with ABI. Implementing a group treatment programme based on music therapy applied to patients with ABI.

Interventions

BEHAVIORALMERAKI_ABI

The music therapy session will focus on the themes of reidentification and involvement. The aim is to accompany the patient during the illness process, allowing them to express their emotional state, relate to music, promote listening and communication between family members, help and value preserved abilities, and promote personal involvement in the rehabilitation process. The session will work with songs, taking into account musical preferences.

Sponsors

University of Valencia
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with acquired brain damage who has been admitted to the hospital for at least one week. The patient has experienced a sudden brain injury resulting in physical, psychological, cognitive, behavioural or sensory deficits that have reduced their previous functional capacity and quality of life. The patient is clinically stable enough to undergo rehabilitation and had a good functional situation prior to the episode (Barthel Index \> 60). * Be over 18 years of age. * The participant or their relatives have signed the informed consent form. * They have completed the group music therapy intervention session, as well as the pre-test and post-test evaluations.

Exclusion criteria

* Failure to obtain informed consent * The Barthel Index score is below 60, indicating functional dependency.

Design outcomes

Primary

MeasureTime frameDescription
Change in Discomfort ( Baseline (3 Assessments), Pre- Post)Baseline up to 1 weekThe Discomfort Observation Scale (DOS) is a tool used to assess discomfort in patients with severe cognitive impairment in end-of-life situations. The Discomfort Observation Scale (DOS) is a tool used to assess discomfort in patients with severe cognitive impairment in end-of-life situations. The Discomfort Observation Scale (DOS) is a tool used to assess discomfort in patients with severe cognitive impairment in end-of-life situations. It consists of nine items that evaluate factors such as noisy breathing, body language, facial expressions, and verbalizations. Each observation is scored dichotomously (0-1, presence-absence), resulting in a score range of 0 to 9. A higher score indicates less discomfort. The language used is clear, concise, and objective, adhering to formal register and precise word choice. The text is grammatically correct and follows conventional structure and formatting features.

Secondary

MeasureTime frameDescription
Barthel IndexBaselineThe purpose of this assessment is to evaluate the patient's functional independence. It involves assessing their ability to perform 10 activities of daily living, including eating, washing, dressing, grooming, bowel movements, urination, toileting, transferring, ambulation, and stair use. The scores range from 0, indicating maximum dependence, to 100, indicating maximum independence.
Pfeiffer Short Form Mental State Questionnaire, SPMSQBaselineThis assessment evaluates cognitive impairment through a series of 10 questions that explore orientation, remote and working memory, as well as calculation skills. Each incorrectly answered question adds one point, and more than 2 errors suggest the presence of cognitive impairment that requires further study.
Charlson Comorbidity Index (CCI),BaselineThis tool predicts the one-year mortality rate for patients with various comorbid conditions, including heart disease, AIDS, and cancer (a total of 8 conditions in the short version). The measure assigns a score to each condition based on the associated risk of death. A score of 0 to 1 indicates no comorbidity, 2 points indicates low comorbidity, and 3 points or more indicates high comorbidity. The total score predicts mortality.

Countries

Spain

Contacts

PRINCIPAL_INVESTIGATORMarián Pérez-Marín, PhD

University of Valencia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 19, 2026